• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素化血浆中一步法和两步法凝血因子 VIII 检测在测定 VIII 因子促凝活性(VIIIC)方面的差异。

Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma.

作者信息

Rock G, Palmer D S

出版信息

Thromb Haemost. 1985 Dec 17;54(4):780-3.

PMID:3937275
Abstract

The level of Factor VIII procoagulant activity (VIIIC) was found to be more than 30% higher in heparinized plasma than in citrated plasma from the same donor when determined by a one-stage assay (1.34 U/ml versus 1.0 U/ml). However, after Al(OH)3 adsorption and two-stage assay, the VIIIC levels were not significantly different for the two types of plasma (0.90 +/- 0.25 U/ml versus 0.82 +/- 0.23 U/ml). If a one-stage assay was employed after adsorption, a similar low result was obtained (0.92 +/- 0.21 U/ml versus 0.91 +/- 0.12 U/ml). This indicated that the adsorption step itself was responsible for the difference in results. Parallel analyses of other VIII markers demonstrated that more VIIIC antigen (VIIICAg) was removed by adsorption of heparinized rather than citrated plasma (0.33 U/ml versus 0.12 U/ml) although there was no difference in the level of VIII-related antigen (VIIIRAg). The results show that adsorption of heparinized plasma prior to either one- or two-stage assay leads to a greater loss of both VIIIC and VIIICAg activity than observed with citrated plasma and indicate that, when applied to heparin plasma the two-stage assay for VIIIC underestimates the actual VIIIC content.

摘要

通过一步法检测发现,同一供体的肝素化血浆中凝血因子VIII促凝活性(VIIIC)水平比枸橼酸化血浆中的高30%以上(分别为1.34 U/ml和1.0 U/ml)。然而,经氢氧化铝吸附和两步法检测后,两种血浆的VIIIC水平无显著差异(分别为0.90±0.25 U/ml和0.82±0.23 U/ml)。如果吸附后采用一步法检测,也会得到类似的低结果(分别为0.92±0.21 U/ml和0.91±0.12 U/ml)。这表明吸附步骤本身导致了结果差异。对其他VIII标志物的平行分析表明,肝素化血浆吸附后去除的VIIIC抗原(VIIICAg)比枸橼酸化血浆更多(分别为0.33 U/ml和0.12 U/ml),尽管VIII相关抗原(VIIIRAg)水平无差异。结果表明,在一步法或两步法检测前对肝素化血浆进行吸附,导致VIIIC和VIIICAg活性的损失比枸橼酸化血浆更大,这表明,将两步法用于检测肝素化血浆中的VIIIC时,会低估实际的VIIIC含量。

相似文献

1
Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma.肝素化血浆中一步法和两步法凝血因子 VIII 检测在测定 VIII 因子促凝活性(VIIIC)方面的差异。
Thromb Haemost. 1985 Dec 17;54(4):780-3.
2
Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.用乙二胺四乙酸(EDTA)分离凝血因子VIII促凝抗原VIII:CAg和凝血因子VIII相关抗原VIIIR:Ag——二价阳离子对VIII:CAg和VIIIR:Ag结合的影响
Thromb Haemost. 1983 Aug 30;50(2):547-51.
3
Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.凝血因子 VIII 促凝抗原回收率是对凝血因子 VIII 浓缩剂输注的剂量相关反应。
Haemostasis. 1984;14(4):296-301. doi: 10.1159/000215078.
4
The stability of factor VIII in heparinized plasma.
Thromb Haemost. 1983 Jun 28;49(3):224-7.
5
Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.正常人和血管性血友病患者中凝血因子VIII促凝抗原及因子VIII相关抗原的凝胶过滤模式
Thromb Haemost. 1983 Aug 30;50(2):509-12.
6
Carrier detection in haemophilia a by immunological measurement of factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg).通过对VIII因子相关抗原(VIIIRAg)和VIII因子凝血抗原(VIIICAg)进行免疫学检测来进行血友病A的携带者检测。
Br J Haematol. 1981 Aug;48(4):651-60. doi: 10.1111/j.1365-2141.1981.00651.x.
7
Heterogeneity of human procoagulant factor VIII (VIIIC) antibodies in their reaction with factor VIII related antigen (VIIIRAG).人促凝血因子VIII(VIIIC)抗体与因子VIII相关抗原(VIIIRAG)反应的异质性
Thromb Res. 1984 Jun 1;34(5):379-87. doi: 10.1016/0049-3848(84)90242-1.
8
A rapid one-step immunoradiometric assay for factor VIII-procoagulant antigen utilizing monoclonal antibodies.一种利用单克隆抗体的快速一步免疫放射分析法定量测定凝血因子VIII促凝抗原。
Thromb Haemost. 1983 Dec 30;50(4):860-3.
9
[Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].[使用抑制剂试验测定凝血因子 VIII 浓缩物中 VIII 因子-凝血抗原]
Arzneimittelforschung. 1986;36(1):124-6.
10
Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.临床中间纯度凝血因子VIII浓缩物生产过程中凝血因子VIII复合物活性的变化
Thromb Haemost. 1981 Oct;46(3):597-601.